Divalproex Sodium Capsule, Delayed Release
Product Images NDC 55111-532

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 55111-532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container (Container)

The packaging label for Divalproex Sodium Delayed-Release Capsules, USP shows a strength of 125 mg with valproic acid activity. It is a 100 capsule bottle labeled for oral use. The label instructs pharmacists to dispense a medication guide to patients and identifies Dr. Reddy's Laboratories Ltd as the labeler, with the product manufactured in India. The label includes an NDC barcode and various usage and storage instructions.*

FDA Label Image

Figure1 (Figure1)

A line graph comparing percentage reduction in CPS rate between Divalproex Sodium and Placebo. The Y-axis represents % reduction in CPS rate, ranging from -100% (worsening) to 100% (improvement), and the X-axis shows the percentage of patients from 0 to 100%. The solid line represents Divalproex Sodium, showing a higher percentage of improvement compared to the dashed line for Placebo.*

FDA Label Image

Figure2 (Figure2)

A chart showing the percentage reduction in CPS rate relative to the percentage of patients, comparing high dose and low dose treatments. The y-axis indicates improvement or worsening with a scale from -100% to 100% reduction, while the x-axis represents the percentage of patients from 0 to 100. Two trend lines are shown: one solid for high dose and one dashed for low dose.*

FDA Label Image

Picture1 (Picture1)

Divalproex sodium 125 mg delayed-release capsule in a clear bottle with a black cap, partially visible in a hand. The label shows the brand name abbreviation and other text not fully legible. The product is labeled by Dr. Reddy's Laboratories Ltd.*

FDA Label Image

Picture2 (Picture2)

Divalproex sodium delayed release capsules, 125 mg strength, manufactured by Dr. Reddy's Laboratories Ltd. The image shows a close-up of a white capsule imprinted with the marking 'D V 5 2' on its body.*

FDA Label Image

Picture3 (Picture3)

Divalproex sodium 125 mg delayed-release capsules shown in an open capsule form with granules spilling out. The labeler is Dr. Reddy's Laboratories Ltd. The image highlights the oral capsule dosage form.*

FDA Label Image

Picture4 (Picture4)

An instructional illustration showing a child taking oral medication using a syringe or dropper. The image demonstrates the administration process, specifically for oral dosage forms, likely related to dispensing the drug to pediatric patients.*

FDA Label Image

Structure (Structure)

Chemical structure of divalproex sodium, a compound consisting of valproate ions complexed with sodium ions, depicted with carbon chains and carboxylate groups in a repeating polymeric form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.